Joaquin Espinosa
Concepts (472)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 33 | 2026 | 525 | 8.690 |
Why?
| | Tumor Suppressor Protein p53 | 17 | 2025 | 534 | 4.420 |
Why?
| | Transcription, Genetic | 13 | 2021 | 1454 | 2.010 |
Why?
| | Transcriptome | 7 | 2026 | 1038 | 1.850 |
Why?
| | Cyclin-Dependent Kinases | 7 | 2022 | 122 | 1.840 |
Why?
| | Neoplasms | 12 | 2026 | 2906 | 1.660 |
Why?
| | Transcriptional Activation | 7 | 2023 | 372 | 1.650 |
Why?
| | Proteome | 6 | 2026 | 514 | 1.570 |
Why?
| | Janus Kinase Inhibitors | 2 | 2024 | 28 | 1.510 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 42 | 1.420 |
Why?
| | Piperidines | 2 | 2024 | 222 | 1.360 |
Why?
| | Interferons | 5 | 2026 | 186 | 1.350 |
Why?
| | Pyrimidines | 3 | 2024 | 530 | 1.250 |
Why?
| | Hypoxia | 3 | 2026 | 1199 | 1.020 |
Why?
| | Receptors, Interferon | 3 | 2026 | 60 | 1.020 |
Why?
| | Common Data Elements | 1 | 2026 | 18 | 0.970 |
Why?
| | Human Development | 1 | 2025 | 20 | 0.910 |
Why?
| | Genomics | 2 | 2021 | 825 | 0.900 |
Why?
| | Metabolome | 3 | 2026 | 388 | 0.890 |
Why?
| | Antineoplastic Agents | 5 | 2025 | 2214 | 0.870 |
Why?
| | Gene Regulatory Networks | 2 | 2021 | 317 | 0.860 |
Why?
| | Immunoglobulins | 1 | 2025 | 162 | 0.840 |
Why?
| | Erythropoiesis | 1 | 2024 | 57 | 0.840 |
Why?
| | Heme | 1 | 2024 | 89 | 0.810 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 160 | 0.790 |
Why?
| | Gene Expression Regulation, Neoplastic | 8 | 2021 | 1443 | 0.760 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.760 |
Why?
| | Interferon-alpha | 3 | 2020 | 193 | 0.740 |
Why?
| | Cell Death | 2 | 2025 | 382 | 0.710 |
Why?
| | Transcription Factors | 9 | 2023 | 1734 | 0.700 |
Why?
| | Humans | 78 | 2026 | 145474 | 0.700 |
Why?
| | Molecular Targeted Therapy | 1 | 2025 | 439 | 0.700 |
Why?
| | Heart Defects, Congenital | 3 | 2026 | 910 | 0.700 |
Why?
| | Blood | 1 | 2022 | 107 | 0.690 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 15 | 0.690 |
Why?
| | Artificial Intelligence | 1 | 2026 | 381 | 0.680 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 85 | 0.650 |
Why?
| | Apoptosis | 11 | 2025 | 2440 | 0.640 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 6 | 2025 | 67 | 0.640 |
Why?
| | Oncogenes | 1 | 2021 | 118 | 0.630 |
Why?
| | Databases, Genetic | 1 | 2021 | 238 | 0.620 |
Why?
| | Kynurenine | 2 | 2023 | 114 | 0.620 |
Why?
| | Sex Characteristics | 1 | 2025 | 782 | 0.610 |
Why?
| | Trisomy | 2 | 2019 | 78 | 0.600 |
Why?
| | Signal Transduction | 9 | 2024 | 5216 | 0.580 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 321 | 0.560 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 191 | 0.560 |
Why?
| | Cyclin-Dependent Kinase 8 | 6 | 2022 | 50 | 0.560 |
Why?
| | Autoimmunity | 2 | 2023 | 933 | 0.520 |
Why?
| | Animals | 32 | 2026 | 38030 | 0.510 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 418 | 0.510 |
Why?
| | Case-Control Studies | 7 | 2025 | 3623 | 0.510 |
Why?
| | CD57 Antigens | 1 | 2016 | 18 | 0.470 |
Why?
| | Abatacept | 1 | 2016 | 56 | 0.470 |
Why?
| | Cell Proliferation | 7 | 2025 | 2507 | 0.460 |
Why?
| | Adult | 20 | 2026 | 40777 | 0.440 |
Why?
| | Mice | 18 | 2026 | 18329 | 0.420 |
Why?
| | Interferon-gamma | 3 | 2026 | 784 | 0.420 |
Why?
| | Cell Line, Tumor | 9 | 2023 | 3542 | 0.410 |
Why?
| | Female | 33 | 2026 | 78844 | 0.410 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 641 | 0.390 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2024 | 296 | 0.390 |
Why?
| | Proteomics | 4 | 2025 | 1188 | 0.390 |
Why?
| | Cyclins | 3 | 2022 | 79 | 0.370 |
Why?
| | Gene Expression Profiling | 5 | 2024 | 1767 | 0.370 |
Why?
| | Male | 25 | 2026 | 72842 | 0.360 |
Why?
| | Young Adult | 10 | 2026 | 14218 | 0.360 |
Why?
| | Graft Rejection | 1 | 2016 | 521 | 0.360 |
Why?
| | Datasets as Topic | 2 | 2022 | 118 | 0.340 |
Why?
| | Adolescent | 11 | 2026 | 22529 | 0.340 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 838 | 0.330 |
Why?
| | Alzheimer Disease | 3 | 2025 | 630 | 0.330 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2023 | 1140 | 0.320 |
Why?
| | Cell Differentiation | 3 | 2024 | 2046 | 0.320 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 630 | 0.320 |
Why?
| | RNA Polymerase II | 4 | 2019 | 350 | 0.310 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2019 | 218 | 0.310 |
Why?
| | Cell Line | 5 | 2021 | 2823 | 0.300 |
Why?
| | Child, Preschool | 8 | 2026 | 11853 | 0.300 |
Why?
| | Kidney Transplantation | 1 | 2016 | 712 | 0.290 |
Why?
| | Biomarkers | 5 | 2025 | 4295 | 0.290 |
Why?
| | Mediator Complex | 3 | 2022 | 61 | 0.290 |
Why?
| | Early Detection of Cancer | 2 | 2026 | 485 | 0.260 |
Why?
| | DNA-Binding Proteins | 4 | 2016 | 1480 | 0.260 |
Why?
| | Proto-Oncogene Proteins | 2 | 2023 | 624 | 0.260 |
Why?
| | Child | 11 | 2026 | 22707 | 0.250 |
Why?
| | Promoter Regions, Genetic | 4 | 2013 | 1246 | 0.250 |
Why?
| | Gene Expression Regulation | 3 | 2012 | 2597 | 0.250 |
Why?
| | Trypanosoma cruzi | 4 | 2000 | 39 | 0.250 |
Why?
| | Flow Cytometry | 3 | 2019 | 1162 | 0.250 |
Why?
| | Cytokines | 5 | 2024 | 2067 | 0.250 |
Why?
| | Disease Models, Animal | 7 | 2026 | 4560 | 0.240 |
Why?
| | Phenotype | 2 | 2026 | 3155 | 0.240 |
Why?
| | Candidiasis, Oral | 1 | 2026 | 19 | 0.240 |
Why?
| | Middle Aged | 13 | 2026 | 36215 | 0.240 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2006 | 29 | 0.230 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2009 | 105 | 0.230 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2026 | 147 | 0.230 |
Why?
| | Cell Cycle | 2 | 2008 | 598 | 0.230 |
Why?
| | Platelet Activation | 1 | 2026 | 99 | 0.230 |
Why?
| | Phosphorylation | 4 | 2022 | 1707 | 0.230 |
Why?
| | Medical Informatics | 1 | 2026 | 99 | 0.220 |
Why?
| | Natural Language Processing | 1 | 2026 | 106 | 0.220 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2664 | 0.220 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2025 | 161 | 0.210 |
Why?
| | Metabolomics | 2 | 2021 | 732 | 0.210 |
Why?
| | Heart | 2 | 2025 | 626 | 0.210 |
Why?
| | Mechanotransduction, Cellular | 1 | 2025 | 121 | 0.210 |
Why?
| | Protein Binding | 5 | 2021 | 2238 | 0.210 |
Why?
| | Polymerase Chain Reaction | 2 | 2019 | 1041 | 0.210 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 14 | 0.200 |
Why?
| | Erythropoietin | 1 | 2024 | 100 | 0.200 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 523 | 0.190 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 209 | 0.190 |
Why?
| | Liposarcoma | 1 | 2023 | 31 | 0.190 |
Why?
| | Glutamine | 1 | 2023 | 109 | 0.190 |
Why?
| | Hypertension, Pulmonary | 2 | 2026 | 1957 | 0.190 |
Why?
| | Cyclin C | 1 | 2022 | 2 | 0.190 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 32 | 0.190 |
Why?
| | Growth Disorders | 1 | 2022 | 89 | 0.180 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 100 | 0.180 |
Why?
| | Centrosome | 2 | 2022 | 71 | 0.180 |
Why?
| | Nuclear Proteins | 4 | 2023 | 740 | 0.180 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 73 | 0.180 |
Why?
| | Gene Silencing | 1 | 2023 | 202 | 0.180 |
Why?
| | Nervous System Diseases | 1 | 2025 | 286 | 0.170 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 177 | 0.170 |
Why?
| | Acetyltransferases | 1 | 2001 | 27 | 0.170 |
Why?
| | Up-Regulation | 3 | 2021 | 847 | 0.170 |
Why?
| | Medulloblastoma | 1 | 2023 | 215 | 0.170 |
Why?
| | Stress, Physiological | 1 | 2024 | 443 | 0.170 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.170 |
Why?
| | Hematopoiesis | 2 | 2021 | 193 | 0.170 |
Why?
| | Cilia | 2 | 2022 | 173 | 0.160 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 29 | 0.160 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 26 | 0.160 |
Why?
| | Azetidines | 1 | 2020 | 45 | 0.160 |
Why?
| | RNA, Messenger | 4 | 2021 | 2803 | 0.160 |
Why?
| | MicroRNAs | 2 | 2018 | 686 | 0.160 |
Why?
| | Models, Biological | 1 | 2008 | 1764 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 317 | 0.160 |
Why?
| | Data Mining | 1 | 2021 | 113 | 0.160 |
Why?
| | Doxorubicin | 3 | 2007 | 401 | 0.160 |
Why?
| | Autoantigens | 1 | 2023 | 427 | 0.150 |
Why?
| | Eosinophilic Esophagitis | 1 | 2024 | 331 | 0.150 |
Why?
| | Quinolinic Acid | 1 | 2019 | 7 | 0.150 |
Why?
| | Heart Diseases | 1 | 2023 | 341 | 0.150 |
Why?
| | Connective Tissue Diseases | 1 | 2020 | 85 | 0.150 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 24 | 0.150 |
Why?
| | DNA, Protozoan | 1 | 1999 | 32 | 0.150 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 56 | 0.150 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 318 | 0.150 |
Why?
| | Liver | 2 | 2026 | 1896 | 0.150 |
Why?
| | Transcription Factor AP-1 | 1 | 1999 | 79 | 0.150 |
Why?
| | Sex Determination Analysis | 1 | 2019 | 10 | 0.140 |
Why?
| | Preimplantation Diagnosis | 1 | 2019 | 7 | 0.140 |
Why?
| | Neurons | 2 | 2025 | 1649 | 0.140 |
Why?
| | Protein Domains | 2 | 2017 | 311 | 0.140 |
Why?
| | Blastocyst | 1 | 2019 | 50 | 0.140 |
Why?
| | Protozoan Proteins | 1 | 1999 | 90 | 0.140 |
Why?
| | Occult Blood | 1 | 2018 | 40 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 467 | 0.140 |
Why?
| | Tibia | 1 | 2020 | 176 | 0.140 |
Why?
| | Calcinosis | 1 | 2020 | 234 | 0.140 |
Why?
| | Cell Survival | 2 | 2021 | 1100 | 0.140 |
Why?
| | Genome, Human | 1 | 2021 | 420 | 0.140 |
Why?
| | Coinfection | 1 | 2020 | 143 | 0.140 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 15 | 0.140 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 67 | 0.140 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 33 | 0.140 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 18 | 0.140 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 76 | 0.140 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 5983 | 0.140 |
Why?
| | Kidney Function Tests | 2 | 2016 | 156 | 0.130 |
Why?
| | Embryo, Mammalian | 1 | 2019 | 234 | 0.130 |
Why?
| | Electronic Health Records | 1 | 2026 | 1196 | 0.130 |
Why?
| | Stem Cell Niche | 1 | 2018 | 57 | 0.130 |
Why?
| | Bacterial Infections | 1 | 2020 | 246 | 0.130 |
Why?
| | Epithelial Cells | 1 | 2024 | 1131 | 0.130 |
Why?
| | Receptor, Notch1 | 1 | 2018 | 63 | 0.130 |
Why?
| | Cell Lineage | 1 | 2019 | 377 | 0.130 |
Why?
| | Hypersensitivity | 1 | 2020 | 254 | 0.130 |
Why?
| | Horses | 1 | 2019 | 226 | 0.130 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 454 | 0.130 |
Why?
| | Reminder Systems | 1 | 2018 | 140 | 0.130 |
Why?
| | Inflammation | 2 | 2020 | 2878 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 553 | 0.130 |
Why?
| | Binding Sites | 3 | 2014 | 1310 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2023 | 919 | 0.130 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 187 | 0.130 |
Why?
| | Cellular Senescence | 1 | 2019 | 226 | 0.130 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 4 | 0.130 |
Why?
| | Hedgehog Proteins | 1 | 2018 | 200 | 0.130 |
Why?
| | Prospective Studies | 3 | 2025 | 8057 | 0.130 |
Why?
| | Proteins | 1 | 2023 | 1023 | 0.120 |
Why?
| | Febrile Neutropenia | 1 | 2016 | 6 | 0.120 |
Why?
| | Osteoarthritis, Knee | 1 | 2020 | 280 | 0.120 |
Why?
| | T-Lymphocytes | 2 | 2022 | 1996 | 0.120 |
Why?
| | Cohort Studies | 2 | 2026 | 6013 | 0.120 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.120 |
Why?
| | Sulfonamides | 1 | 2020 | 583 | 0.120 |
Why?
| | Osteosarcoma | 1 | 2017 | 82 | 0.120 |
Why?
| | Antigens | 1 | 2018 | 348 | 0.120 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 409 | 0.120 |
Why?
| | Exosomes | 1 | 2017 | 104 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 2 | 2020 | 981 | 0.120 |
Why?
| | Proteolysis | 1 | 2017 | 172 | 0.120 |
Why?
| | Chromatin | 4 | 2016 | 553 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 159 | 0.110 |
Why?
| | HCT116 Cells | 3 | 2019 | 76 | 0.110 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1132 | 0.110 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 257 | 0.110 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5423 | 0.110 |
Why?
| | Neurofilament Proteins | 3 | 2025 | 79 | 0.110 |
Why?
| | Autophagy | 1 | 2018 | 291 | 0.110 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 93 | 0.110 |
Why?
| | Drug Resistance | 1 | 2016 | 145 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1149 | 0.110 |
Why?
| | Allografts | 1 | 2016 | 152 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 591 | 0.110 |
Why?
| | Patient Participation | 1 | 2018 | 439 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 435 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1969 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 409 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 259 | 0.110 |
Why?
| | Gene Expression | 1 | 2019 | 1476 | 0.110 |
Why?
| | Azepines | 1 | 2015 | 105 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2017 | 429 | 0.100 |
Why?
| | Infant | 3 | 2025 | 10077 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2018 | 728 | 0.100 |
Why?
| | Acetylation | 2 | 2007 | 259 | 0.100 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2013 | 11 | 0.100 |
Why?
| | Fibroblasts | 1 | 2019 | 1025 | 0.100 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 749 | 0.100 |
Why?
| | Mitogens | 1 | 2013 | 55 | 0.100 |
Why?
| | Bile Acids and Salts | 2 | 2026 | 163 | 0.100 |
Why?
| | Immunologic Memory | 1 | 2016 | 368 | 0.100 |
Why?
| | Down-Regulation | 1 | 2015 | 618 | 0.100 |
Why?
| | Spain | 3 | 2025 | 50 | 0.100 |
Why?
| | Prognosis | 3 | 2019 | 4316 | 0.100 |
Why?
| | Graft Survival | 1 | 2016 | 518 | 0.100 |
Why?
| | Disease Progression | 1 | 2021 | 2864 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1716 | 0.090 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 174 | 0.090 |
Why?
| | Feedback, Physiological | 1 | 2012 | 80 | 0.090 |
Why?
| | Amphotericin B | 1 | 2012 | 36 | 0.090 |
Why?
| | Obesity | 1 | 2026 | 3116 | 0.090 |
Why?
| | Tumor Cells, Cultured | 3 | 2019 | 886 | 0.090 |
Why?
| | Glomerular Filtration Rate | 1 | 2016 | 765 | 0.090 |
Why?
| | RNA Stability | 1 | 2012 | 107 | 0.090 |
Why?
| | United States | 2 | 2026 | 16098 | 0.090 |
Why?
| | Antifungal Agents | 1 | 2012 | 151 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2006 | 855 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 866 | 0.080 |
Why?
| | Risk Factors | 3 | 2025 | 10885 | 0.080 |
Why?
| | Mass Screening | 1 | 2018 | 1360 | 0.080 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 599 | 0.080 |
Why?
| | HeLa Cells | 3 | 2013 | 632 | 0.080 |
Why?
| | Sirtuins | 1 | 2010 | 50 | 0.070 |
Why?
| | Imidazoles | 2 | 2023 | 247 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 456 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2008 | 762 | 0.070 |
Why?
| | S Phase | 1 | 2009 | 78 | 0.070 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.070 |
Why?
| | Histones | 2 | 2007 | 666 | 0.070 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2008 | 18 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2588 | 0.070 |
Why?
| | Hydroxyurea | 2 | 2023 | 34 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2012 | 425 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2930 | 0.070 |
Why?
| | Piperazines | 2 | 2023 | 375 | 0.070 |
Why?
| | RNA | 1 | 2014 | 910 | 0.070 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2025 | 122 | 0.070 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2007 | 42 | 0.060 |
Why?
| | Multiprotein Complexes | 1 | 2008 | 172 | 0.060 |
Why?
| | Protein Kinases | 1 | 2009 | 312 | 0.060 |
Why?
| | Formaldehyde | 1 | 2007 | 65 | 0.060 |
Why?
| | Genome-Wide Association Study | 2 | 2025 | 1407 | 0.060 |
Why?
| | Radiation, Ionizing | 1 | 2007 | 86 | 0.060 |
Why?
| | Glycolysis | 2 | 2024 | 340 | 0.060 |
Why?
| | RNA Precursors | 1 | 2007 | 154 | 0.060 |
Why?
| | DNA | 2 | 2006 | 1435 | 0.060 |
Why?
| | Fluorouracil | 1 | 2007 | 231 | 0.060 |
Why?
| | Kinetics | 2 | 2007 | 1567 | 0.060 |
Why?
| | Endocardial Cushions | 1 | 2025 | 7 | 0.060 |
Why?
| | High Mobility Group Proteins | 1 | 2006 | 45 | 0.060 |
Why?
| | Transcription Factors, TFII | 1 | 2006 | 44 | 0.060 |
Why?
| | Transcriptional Elongation Factors | 1 | 2006 | 39 | 0.060 |
Why?
| | Critical Illness | 1 | 2012 | 900 | 0.060 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2006 | 139 | 0.060 |
Why?
| | Transcription Factor TFIIH | 1 | 2006 | 40 | 0.060 |
Why?
| | Protein Transport | 1 | 2007 | 442 | 0.060 |
Why?
| | Candida albicans | 1 | 2026 | 61 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.060 |
Why?
| | Serine | 1 | 2006 | 143 | 0.060 |
Why?
| | SEER Program | 1 | 2026 | 229 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2019 | 3124 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2382 | 0.050 |
Why?
| | Kidney | 1 | 2012 | 1497 | 0.050 |
Why?
| | Myocytes, Cardiac | 2 | 2025 | 546 | 0.050 |
Why?
| | Glucose | 1 | 2010 | 1048 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2006 | 397 | 0.050 |
Why?
| | Aged | 6 | 2025 | 26153 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2026 | 344 | 0.050 |
Why?
| | Vascular Remodeling | 1 | 2026 | 209 | 0.050 |
Why?
| | Hemoglobin, Sickle | 1 | 2023 | 20 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 977 | 0.050 |
Why?
| | Headache | 1 | 2025 | 151 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2019 | 934 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 66 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 25 | 0.050 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 22 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 41 | 0.050 |
Why?
| | Proline | 1 | 2023 | 82 | 0.050 |
Why?
| | L-Selectin | 1 | 2023 | 27 | 0.050 |
Why?
| | Perforin | 1 | 2023 | 22 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2026 | 17291 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 217 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 48 | 0.050 |
Why?
| | Blood Platelets | 1 | 2026 | 379 | 0.050 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 273 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2025 | 8333 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 167 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 155 | 0.050 |
Why?
| | Esophagus | 1 | 2024 | 262 | 0.040 |
Why?
| | Cells, Cultured | 3 | 2018 | 4148 | 0.040 |
Why?
| | Hemolysis | 1 | 2023 | 242 | 0.040 |
Why?
| | Centrioles | 1 | 2022 | 47 | 0.040 |
Why?
| | DNA Footprinting | 1 | 2001 | 33 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 156 | 0.040 |
Why?
| | Neuroimaging | 1 | 2024 | 297 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2025 | 562 | 0.040 |
Why?
| | p300-CBP Transcription Factors | 1 | 2001 | 25 | 0.040 |
Why?
| | Nitric Oxide | 2 | 1997 | 892 | 0.040 |
Why?
| | Nerve Regeneration | 1 | 2001 | 58 | 0.040 |
Why?
| | Genes, Protozoan | 1 | 2000 | 13 | 0.040 |
Why?
| | Immunoblotting | 1 | 2001 | 295 | 0.040 |
Why?
| | RNA Helicases | 1 | 2000 | 27 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2001 | 57 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 47 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2022 | 271 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2025 | 1134 | 0.040 |
Why?
| | Microtubules | 1 | 2022 | 265 | 0.040 |
Why?
| | Oligonucleotide Probes | 1 | 1999 | 48 | 0.040 |
Why?
| | Electrophoresis | 1 | 1999 | 31 | 0.040 |
Why?
| | Heterozygote | 1 | 2020 | 313 | 0.040 |
Why?
| | Vesiculovirus | 1 | 2019 | 17 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2020 | 176 | 0.040 |
Why?
| | Interferon Type I | 1 | 2020 | 147 | 0.040 |
Why?
| | Genetic Testing | 1 | 2022 | 480 | 0.040 |
Why?
| | Purines | 1 | 2020 | 187 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 193 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 1999 | 54 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 66 | 0.040 |
Why?
| | Veterinary Sports Medicine | 1 | 2019 | 1 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2001 | 237 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 12 | 0.040 |
Why?
| | Argentina | 1 | 2019 | 30 | 0.040 |
Why?
| | Osteotomy | 1 | 2020 | 128 | 0.040 |
Why?
| | Postal Service | 1 | 2018 | 27 | 0.040 |
Why?
| | Biopsy | 2 | 2019 | 1082 | 0.040 |
Why?
| | Prevalence | 1 | 2026 | 2865 | 0.040 |
Why?
| | Immunotherapy, Adoptive | 1 | 2022 | 342 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 666 | 0.040 |
Why?
| | Breeding | 1 | 2019 | 63 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 1999 | 196 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2018 | 10 | 0.040 |
Why?
| | Embryo Transfer | 1 | 2019 | 45 | 0.040 |
Why?
| | Lymphopoiesis | 1 | 2018 | 27 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 666 | 0.030 |
Why?
| | DNA, Single-Stranded | 1 | 1999 | 117 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 84 | 0.030 |
Why?
| | Arginine | 2 | 1997 | 264 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2026 | 1581 | 0.030 |
Why?
| | Commerce | 1 | 2019 | 80 | 0.030 |
Why?
| | Mice, SCID | 1 | 2019 | 369 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2018 | 133 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 53 | 0.030 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 244 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2158 | 0.030 |
Why?
| | omega-N-Methylarginine | 1 | 1997 | 29 | 0.030 |
Why?
| | Antibodies | 1 | 1999 | 397 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2953 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 17 | 0.030 |
Why?
| | Rats | 1 | 2025 | 5584 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 613 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1179 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 41 | 0.030 |
Why?
| | Pyrazoles | 1 | 2020 | 517 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2025 | 2378 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 361 | 0.030 |
Why?
| | Epilepsy | 1 | 2001 | 390 | 0.030 |
Why?
| | Knee Joint | 1 | 2020 | 428 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 72 | 0.030 |
Why?
| | Mitosis | 1 | 2017 | 193 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 688 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1261 | 0.030 |
Why?
| | African Swine Fever | 1 | 1995 | 1 | 0.030 |
Why?
| | African Swine Fever Virus | 1 | 1995 | 1 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 18 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 408 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 401 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 141 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 61 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 835 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2017 | 314 | 0.030 |
Why?
| | Hospitalization | 1 | 2025 | 2460 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2090 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 959 | 0.030 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 26 | 0.020 |
Why?
| | Genes, ras | 1 | 2013 | 96 | 0.020 |
Why?
| | Protein Conformation | 1 | 2016 | 938 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 146 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2017 | 961 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2018 | 870 | 0.020 |
Why?
| | Lung | 1 | 2026 | 4106 | 0.020 |
Why?
| | Oxidative Stress | 1 | 1999 | 1356 | 0.020 |
Why?
| | Mycoses | 1 | 2012 | 88 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1321 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 1995 | 419 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1808 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 741 | 0.020 |
Why?
| | Creatinine | 1 | 2012 | 515 | 0.020 |
Why?
| | Glucose Transporter Type 1 | 1 | 2010 | 48 | 0.020 |
Why?
| | Cell Respiration | 1 | 2010 | 105 | 0.020 |
Why?
| | Daunorubicin | 1 | 2009 | 25 | 0.020 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2009 | 16 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2009 | 27 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2009 | 27 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 69 | 0.020 |
Why?
| | Coenzymes | 1 | 2008 | 19 | 0.020 |
Why?
| | Caffeine | 1 | 2009 | 74 | 0.020 |
Why?
| | Brain | 1 | 2001 | 2947 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 12 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 387 | 0.020 |
Why?
| | RNA Caps | 1 | 2007 | 32 | 0.020 |
Why?
| | Genes, myc | 1 | 2007 | 51 | 0.020 |
Why?
| | Poly A | 1 | 2007 | 50 | 0.020 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2007 | 24 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 249 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 267 | 0.020 |
Why?
| | Dizocilpine Maleate | 2 | 1997 | 24 | 0.020 |
Why?
| | Cyclic GMP | 2 | 1997 | 90 | 0.010 |
Why?
| | Pregnancy | 1 | 2019 | 7202 | 0.010 |
Why?
| | Nitric Oxide Synthase | 2 | 1997 | 234 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2008 | 730 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1368 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2020 | 11772 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 4075 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1598 | 0.010 |
Why?
| | Genomic Library | 1 | 2000 | 16 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2001 | 414 | 0.010 |
Why?
| | RNA, Protozoan | 1 | 2000 | 60 | 0.010 |
Why?
| | tau Proteins | 1 | 2001 | 105 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 273 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2000 | 219 | 0.010 |
Why?
| | Microtubule-Associated Proteins | 1 | 2001 | 194 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2000 | 506 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2001 | 372 | 0.010 |
Why?
| | Bucladesine | 1 | 1997 | 19 | 0.010 |
Why?
| | Guanosine Monophosphate | 1 | 1997 | 8 | 0.010 |
Why?
| | Guanosine Diphosphate | 1 | 1997 | 20 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2000 | 2129 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2000 | 2883 | 0.010 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 19 | 0.010 |
Why?
| | Guanylate Cyclase | 1 | 1995 | 38 | 0.010 |
Why?
| | Citrulline | 1 | 1995 | 45 | 0.010 |
Why?
| | Glutamic Acid | 1 | 1997 | 255 | 0.010 |
Why?
| | Movement | 1 | 1997 | 293 | 0.010 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 228 | 0.010 |
Why?
| | Amino Acids | 1 | 1997 | 519 | 0.010 |
Why?
| | Brain Neoplasms | 1 | 2001 | 1329 | 0.010 |
Why?
|
|
Espinosa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|